Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127408091 | 12740809 | 1 | I | 20151208 | 20160914 | 20160914 | PER | US-TEVA-617564USA | TEVA | 16.00 | YR | M | Y | 0.00000 | 20160914 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127408091 | 12740809 | 1 | PS | FLUOXETINE | FLUOXETINE HYDROCHLORIDE | 1 | Oral | U | UNKNOWN | 74803 | 10 | MG | TABLET | ||||||
| 127408091 | 12740809 | 2 | C | PROZAC | FLUOXETINE HYDROCHLORIDE | 1 | Oral | 0 | 20 | MG | CAPSULE | ||||||||
| 127408091 | 12740809 | 3 | C | ZYRTEK | CETIRIZINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 127408091 | 12740809 | 4 | C | ADDERALL | AMPHETAMINE ASPARTATEAMPHETAMINE SULFATEDEXTROAMPHETAMINE SACCHARATEDEXTROAMPHETAMINE SULFATE | 1 | 0 |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127408091 | 12740809 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127408091 | 12740809 | Dyspnoea | |
| 127408091 | 12740809 | Incorrect product formulation administered | |
| 127408091 | 12740809 | Malaise | |
| 127408091 | 12740809 | Speech disorder | |
| 127408091 | 12740809 | Throat tightness |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |